MORABITO, Nunziata
 Distribuzione geografica
Continente #
NA - Nord America 10.326
EU - Europa 9.974
AS - Asia 5.164
SA - Sud America 1.625
Continente sconosciuto - Info sul continente non disponibili 393
AF - Africa 146
OC - Oceania 10
Totale 27.638
Nazione #
US - Stati Uniti d'America 10.038
RU - Federazione Russa 5.188
SG - Singapore 2.195
CN - Cina 1.591
BR - Brasile 1.343
IE - Irlanda 1.182
SE - Svezia 1.113
IT - Italia 635
DE - Germania 560
HK - Hong Kong 517
FR - Francia 351
VN - Vietnam 275
FI - Finlandia 255
GB - Regno Unito 178
UA - Ucraina 154
IN - India 146
PL - Polonia 138
CA - Canada 116
AR - Argentina 90
BD - Bangladesh 59
TR - Turchia 55
EC - Ecuador 53
IQ - Iraq 52
MX - Messico 51
BE - Belgio 40
NL - Olanda 40
CO - Colombia 37
ZA - Sudafrica 34
JP - Giappone 33
VE - Venezuela 33
PK - Pakistan 32
AT - Austria 26
ID - Indonesia 26
ES - Italia 25
UZ - Uzbekistan 25
CL - Cile 22
GT - Guatemala 22
HN - Honduras 21
MA - Marocco 21
PY - Paraguay 19
EG - Egitto 17
CI - Costa d'Avorio 16
KR - Corea 15
CZ - Repubblica Ceca 13
JO - Giordania 13
NI - Nicaragua 13
PH - Filippine 13
TT - Trinidad e Tobago 13
AE - Emirati Arabi Uniti 12
CR - Costa Rica 12
IL - Israele 12
UY - Uruguay 12
KE - Kenya 11
LT - Lituania 11
SA - Arabia Saudita 11
AU - Australia 10
AZ - Azerbaigian 10
JM - Giamaica 10
MY - Malesia 10
PE - Perù 9
DZ - Algeria 8
NO - Norvegia 8
SV - El Salvador 8
TN - Tunisia 8
BG - Bulgaria 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NG - Nigeria 7
NP - Nepal 7
SC - Seychelles 7
BH - Bahrain 6
EE - Estonia 6
GP - Guadalupe 6
RO - Romania 6
AL - Albania 5
BO - Bolivia 5
ET - Etiopia 5
CW - ???statistics.table.value.countryCode.CW??? 4
GE - Georgia 4
IR - Iran 4
SN - Senegal 4
AM - Armenia 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 27.220
Città #
Ashburn 1.553
Moscow 1.438
Dublin 1.180
Singapore 1.178
Chandler 866
Dallas 770
San Jose 636
Nyköping 584
Beijing 539
Hong Kong 476
Jacksonville 421
Council Bluffs 287
The Dalles 269
Munich 247
Princeton 215
Dearborn 195
Los Angeles 189
New York 180
Medford 171
Messina 168
Lauterbourg 166
Ann Arbor 156
Cambridge 132
Des Moines 128
Boardman 123
Warsaw 122
Bremen 105
São Paulo 101
Ho Chi Minh City 99
Helsinki 91
Santa Clara 80
Buffalo 76
Tianjin 72
Guangzhou 63
Wilmington 61
Jinan 60
Shenyang 60
Catania 58
Atlanta 57
Hanoi 57
Turku 55
Nanjing 53
Redondo Beach 53
Frankfurt am Main 51
Orem 50
Houston 49
San Mateo 45
Rio de Janeiro 44
Brussels 40
Seattle 40
Pune 37
Belo Horizonte 36
Woodbridge 35
Montreal 34
Hebei 33
North Bergen 32
Curitiba 31
Milan 31
Chennai 29
Chicago 29
Brooklyn 28
Haikou 28
Phoenix 28
Zhengzhou 27
Düsseldorf 26
Nanchang 26
Taizhou 26
Boston 25
Hangzhou 25
Ningbo 25
San Francisco 25
Strasbourg 25
Tokyo 25
Rome 24
Brasília 23
London 23
Shanghai 23
Denver 22
Johannesburg 22
Baghdad 21
Tashkent 21
Newark 20
Fuzhou 19
Nuremberg 19
Guayaquil 18
Lancaster 18
Porto Alegre 18
Toronto 18
Poplar 17
Abidjan 16
Amsterdam 16
Manchester 16
Quito 16
Falls Church 15
Guatemala City 15
Fremont 14
Goiânia 14
Hyderabad 14
Ribeirão Preto 14
Stockholm 14
Totale 15.065
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 318
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 302
Anxiety levels as risk factor for osteoporosis in postmenopausal women 284
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 276
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 262
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 251
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 246
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 242
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 239
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 239
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 235
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 232
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 231
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 225
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 223
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 221
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 217
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 217
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 213
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 211
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 209
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 203
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 203
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 203
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 202
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 200
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 198
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 196
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 195
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 194
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 194
Cardiovascular effects of raloxifene hydrochloride 193
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Amylasemia in uremics: a complex interpretation 188
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 188
Association between anxiety levels and osteoporosis in postmenopausal women. 188
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 184
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 184
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 182
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 179
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 179
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 177
Recombinant erythropoietin and hypertension 175
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 175
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 175
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 175
Frailty and lipid profile in elderly hospitalized patients 174
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 174
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 172
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 172
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 171
Incidence of Hypocalcemia and Hypercalcemia in Elderly Hospitalized Patients 170
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 170
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 170
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 168
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 167
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 167
Amylasemia in uremics: a complex interpretation 164
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 163
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 162
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 162
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 162
Frailty modifications and prognostic impact in older patients admitted in acute care 162
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 161
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 159
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 159
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 159
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 158
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 158
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 157
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 157
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 156
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 156
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 154
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 154
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 154
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 154
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 153
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 153
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 153
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 152
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 151
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 150
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 149
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 148
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 148
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 147
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 147
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 146
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 146
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 145
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 145
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 145
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 144
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 144
L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia 144
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 143
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 143
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 143
Totale 18.275
Categoria #
all - tutte 91.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.242 0 0 0 0 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024923 67 137 43 99 66 200 36 90 6 20 17 142
2024/20254.005 64 74 68 259 216 99 128 784 991 298 351 673
2025/202612.063 618 878 749 800 998 2.503 1.498 1.630 1.569 481 155 184
2026/20272.701 373 1.010 543 729 46 0 0 0 0 0 0 0
Totale 27.638